Clinical Trial Update: Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing adipose-derived mesenchymal stem cells to prevent biliary complications in liver transplant recipients; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Adipose-derived mesenchymal stem cells

Snippet

Sponsor: Mayo Clinic | Conditions: Liver Transplant; Complications, Liver Diseases | Phase 1 | Status: NOT_YET_RECRUITING